The Sci-Tech Innovation Board Medical ETF from China Asset Management, ticker 588130, has recorded consecutive net inflows over the past five trading days, drawing a combined 99.31 million yuan, with an average daily net inflow of 19.86 million yuan. As of 11 a.m. on July 28, the ETF was quoted at 0.99 yuan, with intraday turnover of 8.04 percent and trading volume of 36.07 million yuan. The constituent stocks of the Shanghai Sci-Tech Innovation Board Biomedical Index it tracks were mixed, with Xiangyu Medical leading gains at 9.07 percent. In related news, as of July 27, 100 pharmaceutical and biotech companies listed on the A-share market had disclosed their semi-annual earnings forecasts for 2026, of which 64 expected growth in net profit attributable to the parent company, and 26 projected year-on-year growth exceeding 100 percent.
Xiangyu Medical Co. Ltd. AXiangyu Medical led gains at 9.07% as a constituent of the ETF, reflecting positive sentiment in the biomedical sector.
Inner Mongolia Yuan Xing Energy Co Ltd